Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/15/09 → 3/31/10 |
An Open-Label Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients with Advanced Hematological Malignancies
- McDonagh, Kevin (PI)
| Status | Finished |
|---|---|
| Effective start/end date | 5/15/09 → 3/31/10 |